Glycosmedia Weekly Diabetes News Update
View this email in your browser

Platinum Sponsors:

Gold Sponsors:


Novo Nordisk

Silver Sponsors:

Desang Diabetes Services

Glycosmedia Weekly Diabetes News - 07/22/2016

Sulfonylureas can be considered safe for those with type 2 diabetes

Sulfonylureas are not associated with increased risk for all-cause mortality, cardiovascular mortality, myocardial infarction, or stroke. Current evidence supports the safety of sulfonylureas; an absolute risk of 0.5% could be firmly discarded (NIHR)


Effects of Saturated Fat, Polyunsaturated Fat, Monounsaturated Fat, and Carbohydrate on Glucose-Insulin Homeostasis

This meta-analysis of randomised controlled feeding trials provides evidence that dietary macronutrients have diverse effects on glucose-insulin homeostasis. In comparison to carbohydrate, SFA, or MUFA, most consistent favourable effects were seen with PUFA, which was linked to improved glycaemia, insulin resistance, and insulin secretion capacity (PLOS Medicine)


Obesity and Life Expectancy with and without Diabetes in Adults Aged 55 Years and Older in the Netherlands

Obesity in the middle aged and elderly is associated with a reduction in the number of years lived free of diabetes and an increase in the number of years lived with diabetes. Those extra years lived with morbidity might place a high toll on individuals and health care systems (PLoS Medicine)


Dietary Diversity, Diet Cost, and Incidence of Type 2 Diabetes in the United Kingdom: A Prospective Cohort Study

A diet characterized by regular consumption of all five food groups and by greater variety of dairy, fruit, and vegetable subtypes, appears important for a reduced risk of diabetes. However, such a diet is more expensive. Public health efforts to prevent diabetes should include food price policies to promote healthier, more varied diets (PLoS Medicine)


Type 1 diabetes in adults: diagnosis and management

This guideline covers the care and treatment of adults (aged 18 and over) with type 1 diabetes (NICE)


Type 2 diabetes in adults: management

This guideline covers the care and management of type 2 diabetes in adults (aged 18 and over). It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications (NICE)


Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?

This review focuses on known changes in the routine lipid profile (LDL-C, TGs, and HDL-C) observed with commonly prescribed medications for patients with T2DM, including antihyperglycemic agents, antihypertensive agents, weight loss medications, antibiotics, analgesics, oral contraceptives, and hormone replacement therapies (Cardiovascular Diabetology)


Share
Tweet
Forward
+1
Share

Advertisers:



13th Global Diabetes Conference & Medicare Expo

 

Please visit the Glycosmedia website for more features and information, including:

Journal Watch
Comment on recently published papers written by the medical editors of Glycosmedia.

Diabetes Updates
Updates written by Professor Steve Bain (Diabetologist) and Dr. Mark Freeman (Diabetologist).

Book and Product Reviews
A selection of book and product reviews written by the contributing editors of Glycosmedia.
Our sponsors have kindly provided unrestricted educational grants for the running of Glycosmedia. None of these companies have any input to, or editorial control over content.
 

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

 

Glycosmedia complies with the HONcode standard for trustworthy health information: verify here.


Copyright © 2016 Glycosmedia Partnership

Our mailing address is:
Glycosmedia Partnership
Institute of Life Science, College of Medicine
Swansea University
Swansea, SA2 8PP
United Kingdom

Add us to your address book


unsubscribe from this list    update subscription preferences 

Email Marketing Powered by MailChimp